POSCO's Innovative Demo Plant at Lithium Americas' Cauchari Salar Produces Over Six Tonnes of Lithium

Lithium Americas Corp. is pleased to announce that POSCO's innovative high efficiency lithium extraction demonstration plant operating at LAC's Cauchari salar in Jujuy Province, Argentina, has produced in excess of six tonnes of lithium compound since the formal inauguration of the Demo Plant on December 22, 2014.

These initial six tonnes of lithium compound will now be sent by POSCO to Korea for final processing and packaging, and then delivered for testing to end users and potential customers. POSCO has advised that initial test results indicate that the Demo Plant is achieving or exceeding all initial performance targets as it has operated on a continuous 24 hour production cycle.

To view photo please click on the following link: http://www.marketwire.com/library/20150120-LithiumCompound.jpg

The POSCO extraction process is also capable of producing potash. The potash demonstration plant, located in Jujuy city, is in the final stage of construction and is expected to be in operation in the next few weeks. Both the lithium and potash plants will operate for several weeks, following which LAC expects to commence commercial stage negotiations with POSCO in the spring of 2015.

As previously reported, POSCO, Korea's largest steel company and a leader in the development of advanced material processes, has developed a proprietary and innovative lithium extraction technology which it believes has numerous advantages compared to traditional lithium brine evaporation technology. Specifically, POSCO claims that its technology produces lithium considerably more quickly than traditional brine evaporation technology, minimizes the environmental footprint associated with large scale evaporation ponds used in traditional brine evaporation technology, and has a recovery rate which is significantly higher than traditional brine evaporation technology. The higher recovery rates associated with POSCO's processing technology should result in a project requiring fewer production wells for a given level of production, thereby reducing the capital cost requirements for the wells as compared to traditional evaporation technology. In addition, higher recovery rates would serve to increase the effective size of a lithium resource, thereby extending the life of a project. POSCO's several hundred tonne per year Demo Plant is the final stage test in the commercialization plan for its high efficiency lithium extraction process, having previously successfully operated pilot plants in 2011 and 2013, respectively.

LAC's previously published National Instrument 43-101 compliant Feasibility Study ("FS") was based on the use of traditional evaporation technology. According to the FS results, the resource estimate contained in the Company's Cauchari-Olaroz lithium project is the third largest known lithium brine resource in the world.

LAC's board of directors met in Argentina this past week, visited the Company's Cauchari-Olaroz lithium project, and received a tour of the Demo Plant, conducted by Dr. Uong Chon, head of POSCO's lithium team. Following the Board visit, LAC's Executive Chairman, Tom Hodgson, commented: "We are very encouraged by the positive initial test results of the Demo Plant, and congratulate Dr. Chon and his team for their exceptional efforts in constructing a very impressive facility. We are excited by the many benefits that POSCO's technology is expected to bring to our already world-class lithium resource, and we look forward to beginning commercial stage negotiations in the near future."

Source: http://www.lithiumamericas.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.